查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2024724

子宮內膜異位症市場報告：按類型、診斷和治療、最終用戶和地區分類，2026-2034 年

Endometriosis Market Report by Type, Diagnosis and Treatment, End Users, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 135 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球子宮內膜異位症市場規模達26億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到39億美元，2026年至2034年的複合年成長率（CAGR）為4.30%。全球市場正經歷穩定成長，這主要得益於人們對症狀和診斷的認知不斷提高、各種學名藥的上市、創新治療方法的研發以及臨床試驗的增加。

子宮內膜異位症市場趨勢：

提高認知度和診斷率

推動市場成長的主要因素之一是公眾意識的提高和診斷率的提升。近年來，大眾對子宮內膜異位症（一種子宮內膜樣組織生長在子宮以外的疾病）的認知度顯著提高。這種認知度的提高促使更多女性識別並報告自身症狀，從而實現早期診斷和介入。此外，醫療專業人員對該疾病的了解也日益深入，使得診斷更加準確快速。因此，對有效治療方法和管理方案的需求不斷成長，進而推動了市場成長。

醫學研究和技術進步

醫學研究和持續的技術進步在塑造子宮內膜異位症的治療方案方面發揮了至關重要的作用。創新治療方法的開發，例如新藥、微創手術技術和個人化治療方案，顯著拓寬了患者的治療方法範圍。尖端診斷工具，例如先進的影像技術和生物標記識別，有助於實現更準確、更有效率的診斷。這些進步不僅改善了患者的治療效果，而且透過建立強大的新型高效治療方法管線，推動了市場成長。

醫療保健支出增加和女性就醫途徑改善

全球對女性健康的日益關注以及女性醫療保健支出的不斷成長，正在推動市場擴張。隨著社會各界認知到解決女性健康問題的重要性，越來越多的機構開始積極投入資源，用於子宮內膜異位症相關的研發以及優質醫療保健服務的普及。此外，醫療保健設施的改善，尤其是在發展中地區，使得更多女性能夠獲得醫療服務並接受針對疾病的適當治療。醫療保健支出增加和醫療服務可近性提高的協同效應，為子宮內膜異位症領域的研發和患者照護創造了更有利的環境，從而推動了市場成長。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球子宮內膜異位症市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依類型

  • 表腹膜病變
  • 子宮內膜異位囊腫
  • 深部浸潤型子宮內膜異位症
  • 其他

第7章 市場區隔：依診斷及治療分類

  • 診斷
    • 主要部分
      • 超音波
      • 骨盆腔檢查
      • 腹腔鏡
      • 磁振造影（MRI）
      • 子宮鏡檢查
      • 超音波造影
  • 治療
    • 主要部分
      • 荷爾蒙療法
      • 疼痛管理
      • 保守手術

第8章 市場區隔：依最終用戶分類

  • 醫院
  • 居家醫療
  • 專業醫療中心
  • 其他

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章：促進、抑制與機遇

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Abbott Laboratories
    • Abbvie Inc.
    • Bayer AG
    • Debiopharm Group
    • Gedeon Richter Plc
    • Kissei Pharmaceutical Co. Ltd.
    • Myovant Sciences GmbH
    • Sanofi SA
    • Teva Pharmaceutical Industries Ltd.
Product Code: SR112026A6676

The global endometriosis market size reached USD 2.6 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 3.9 Billion by 2034, exhibiting a growth rate (CAGR) of 4.30% during 2026-2034. The global market is experiencing steady growth driven by the rising awareness about symptoms and diagnosis, the widespread availability of various generic drugs, the development of innovative therapeutic approaches, and the increasing number of clinical trials.

Endometriosis Market Analysis:

Market Growth and Size: The global market is experiencing robust growth, driven by an increasing prevalence of the condition, rising awareness, and advancements in healthcare infrastructure. The market size continues to expand as more individuals seek diagnosis and treatment for endometriosis, fostering a demand for innovative therapeutic solutions and comprehensive healthcare services.

Major Market Drivers: Key drivers include the growing awareness of women's health issues, improved diagnostic capabilities, and a rise in research and development activities. Additionally, the focus on patient-centric care and the introduction of novel treatment options contribute significantly to the market growth.

Technological Advancements: Technological advancements, such as advanced imaging techniques, minimally invasive surgical procedures, and molecular diagnostics, play a pivotal role in shaping the landscape of treatment. These innovations enhance diagnostic accuracy, improve surgical outcomes, and pave the way for personalized treatment approaches.

Industry Applications: The market encompasses a wide range of industry applications, including pharmaceuticals, medical devices, and healthcare services. Pharmaceutical companies are actively developing and commercializing medications, while medical device manufacturers contribute with innovative tools and equipment used in diagnostic and surgical procedures.

Key Market Trends: Key trends include the emphasis on early diagnosis, increasing collaborations between pharmaceutical companies and research institutions, and the integration of telemedicine in patient care. Additionally, a shift towards holistic and patient-centered approaches, addressing not only symptoms but also the emotional and psychological aspects of the condition, is gaining prominence.

Geographical Trends: Geographical trends reveal varying rates of market growth across regions, with North America leading in terms of market share due to advanced healthcare infrastructure. The Asia Pacific region is witnessing substantial growth, driven by a rising prevalence of endometriosis and increasing healthcare awareness.

Competitive Landscape: The competitive landscape is characterized by key players actively contributing to the market's growth through research, development, and strategic partnerships. The market dynamics include a balance between established pharmaceutical companies and emerging players bringing innovation to the forefront.

Challenges and Opportunities: Challenges encompass issues related to delayed diagnosis, limited accessibility to healthcare in certain regions, and the need for more effective long-term management options. Opportunities lie in advancements in research, increased global collaboration, and the potential for breakthrough therapies addressing unmet needs in the market.

Future Outlook: The future of the market appears promising, with sustained growth anticipated. Continued research, technological innovations, and a focus on patient-centered care are expected to drive the development of more effective treatments, further enhancing the overall management of endometriosis. As awareness continues to grow, the market is poised for growth, presenting opportunities for both established and emerging players.

Endometriosis Market Trends:

Increased awareness and diagnosis rates

One of the primary factors fueling the growth of the market is the heightened awareness and improved diagnosis rates. In recent years, there has been a significant increase in public awareness regarding endometriosis, a condition where tissue similar to the lining of the uterus grows outside the uterus. This heightened awareness has led to more women recognizing and reporting symptoms, prompting early diagnosis and intervention. Additionally, healthcare professionals are increasingly knowledgeable about the condition, leading to more accurate and timely diagnoses. As a result, the demand for effective treatments and management options has risen, driving growth in the market.

Advancements in medical research and technology

Ongoing advancements in medical research and technology have played a crucial role in shaping the landscape of endometriosis treatment options. The development of innovative therapeutic approaches, including new medications, minimally invasive surgical techniques, and personalized treatment plans, has significantly expanded the available choices for patients. Cutting-edge diagnostic tools, such as advanced imaging techniques and biomarker identification, contribute to more precise and efficient diagnosis. These advancements not only enhance patient outcomes but also drive market growth by creating a robust pipeline of novel and more effective therapies for this medical disorder.

Increasing female healthcare spending and accessibility

The growing emphasis on women's health and increased healthcare spending among the female population globally has contributed to the expansion of the market. As societies recognize the importance of addressing women's health issues, there is a greater willingness to allocate resources for research, development, and access to quality healthcare services related to endometriosis. Moreover, improved accessibility to healthcare facilities, especially in developing regions, ensures that a larger proportion of women can seek medical attention and receive appropriate treatment for this medical disorder. This combination of increased healthcare spending and enhanced accessibility propels market growth by fostering a more supportive environment for both research and patient care in the field of endometriosis.

Endometriosis Industry Segmentation:

This report provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2026-2034. The report has categorized the market based on type, diagnosis and treatment, and end users.

Breakup by Type:

  • Superficial Peritoneal Lesion
  • Endometrioma
  • Deeply Infiltrating Endometriosis
  • Others

Superficial peritoneal lesions are a common type of this disorder, characterized by the presence of endometrial-like tissue on the peritoneum - the thin membrane lining the abdominal cavity. These lesions often cause inflammation, scarring, and pain. Despite being superficial, they can significantly impact a patient's quality of life. Treatment approaches for superficial peritoneal lesions may include pain management, hormonal therapies, or surgical interventions to remove or ablate the lesions.

On the other hand, endometriomas, also known as ovarian cysts or chocolate cysts, occur when endometriotic tissue forms a cyst on the ovaries. These cysts can vary in size and may lead to pelvic pain, infertility, or complications during menstruation. Management of endometriomas often involves a combination of medical and surgical interventions. Surgical options may include cystectomy to remove the cyst while preserving ovarian tissue or oophorectomy in more severe cases. Hormonal treatments are also commonly employed to manage symptoms and prevent recurrence.

Furthermore, deeply infiltrating endometriosis involves the penetration of endometrial-like tissue into the deeper layers of organs within the pelvic cavity, such as the bowel, bladder, or uterosacral ligaments. This form can cause severe pain, organ dysfunction, and fertility issues. Management of deeply infiltrating endometriosis often requires specialized surgical procedures, such as excision surgery, to remove the deeply embedded tissue. Multidisciplinary care, involving gynecologists and other specialists, is crucial for comprehensive management. Hormonal therapies may also be employed to control symptoms and prevent recurrence in cases of deeply infiltrating endometriosis.

Breakup by Diagnosis and Treatment:

  • Diagnosis
  • Ultrasound
  • Pelvic Exam
  • Laparoscopy
  • Magnetic Resonance Imaging (MRI)
  • Hysteroscopy
  • Sonohysterography
  • Treatment
  • Hormonal Therapy
  • Pain Management
  • Conservative Surgery

The diagnosis involves a multi-faceted approach, combining clinical evaluation, imaging studies, and, in some cases, surgical procedures. Clinicians rely on a detailed medical history, including the description of symptoms such as pelvic pain, dysmenorrhea, and infertility. Physical examinations, including pelvic exams, may provide additional insights. Imaging techniques, such as transvaginal ultrasound or magnetic resonance imaging (MRI), aid in visualizing endometrial lesions and assessing their extent. Definitive diagnosis often requires laparoscopic surgery, allowing direct visualization and biopsy of endometriotic tissue.

On the other hand, the management of this disorder is tailored to individual patient needs and may involve a combination of medical, surgical, and supportive interventions. Hormonal therapies, including birth control pills, progestins, or GnRH agonists, are commonly employed to control symptoms by suppressing estrogen production. Non-steroidal anti-inflammatory drugs (NSAIDs) may be used for pain relief. In cases where fertility is a concern, assisted reproductive technologies (ART) or fertility-preserving surgeries may be considered. Surgical interventions, such as laparoscopic excision or ablation of endometrial lesions, aim to alleviate symptoms and improve fertility. In severe cases, particularly with deeply infiltrating endometriosis, more extensive surgeries may be necessary, involving excision of affected organs or tissues. Multidisciplinary care, involving gynecologists, fertility specialists, and pain management experts, is crucial for comprehensive treatment.

Breakup by End Users:

  • Hospitals
  • Homecare
  • Speciality Centers
  • Others

Hospitals represent the leading market segment

Hospitals serve as critical end-users in the market, playing a central role in diagnosis, treatment, and management of the condition. These institutions provide comprehensive care, including surgical interventions, medication administration, and post-operative monitoring. The collaborative nature of hospital settings facilitates the coordination of multidisciplinary teams, comprising gynecologists, surgeons, and other specialists, ensuring a holistic approach to the medical disi care. Moreover, hospitals often serve as hubs for medical research and innovation, actively contributing to the development of advanced treatment modalities and enhancing the overall landscape of this disorder management.

On the contrary, homecare represents an increasingly important segment in patient care, offering personalized and convenient solutions for individuals managing the chronic nature of the condition. Home-based care involves the administration of medications, pain management strategies, and monitoring of symptoms in the familiar and comfortable environment of patients' homes. This segment has witnessed growth with the advent of telemedicine, allowing healthcare professionals to remotely engage with patients, provide consultations, and monitor treatment adherence. Homecare not only enhances patient comfort but also contributes to cost-effective and efficient healthcare delivery, aligning with the trend toward patient-centric care models in the market.

Moreover, specialty centers dedicated to women's health and gynecological care have emerged as specialized end-users in the market. These centers focus on delivering targeted and specialized services for disorder diagnosis, treatment, and support. With a dedicated focus on gynecological conditions, these centers often house experts in the field, ensuring a high level of expertise and personalized care for patients with endometriosis. The establishment of these centers contributes to streamlined and efficient care pathways, fostering an environment that prioritizes the unique needs of individuals affected by endometriosis. Additionally, specialty centers frequently serve as hubs for clinical trials and research, driving advancements in the understanding and management of this medical disorder.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

North America leads the market, accounting for the largest endometriosis market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America has consistently held a prominent position as the largest market, driven by factors such as advanced healthcare infrastructure, high awareness levels, and a significant focus on women's health. The region benefits from robust research and development activities, leading to the continuous introduction of innovative treatment options. Additionally, increasing awareness campaigns and advocacy efforts contribute to early detection and treatment. The prevalence of endometriosis cases and a well-established healthcare system with access to cutting-edge technologies further solidify North America's dominance in the global market.

The Asia Pacific region is witnessing substantial growth in the market, propelled by a rising prevalence of the condition, improving healthcare infrastructure, and increased awareness. As societies in the region become more attuned to women's health issues, there is a growing emphasis on early diagnosis and effective management of endometriosis. Pharmaceutical companies are expanding their presence in the Asia Pacific, introducing novel therapies and leveraging partnerships to address the changing healthcare needs of the population. Moreover, cultural shifts and changing demographics contribute to a greater focus on women's health in the region, fostering a conducive environment for market expansion.

Europe stands as a significant market, characterized by a high prevalence of the condition and a well-established healthcare system. The region benefits from extensive research initiatives, leading to the development of advanced treatment options. European countries prioritize women's health, and initiatives for early detection and management of endometriosis contribute to market growth. Collaboration between pharmaceutical companies and research institutions enhances the region's capabilities in driving innovations. The European market for endometriosis is characterized by a comprehensive approach to patient care, with a focus on both medical interventions and supportive services.

Latin America is experiencing a growing awareness of the disorder, leading to an expanding market for treatment options. The region grapples with challenges such as limited access to healthcare in certain areas, but initiatives aimed at improving healthcare infrastructure contribute to addressing these issues. Rising advocacy for women's health and increasing efforts to reduce the diagnostic and treatment gap are driving market growth in Latin America. Pharmaceutical companies are exploring opportunities in this region, introducing therapies and collaborating with local healthcare providers to enhance accessibility to endometriosis care.

The Middle East and Africa are emerging markets, marked by a gradual increase in awareness and healthcare infrastructure development. While the prevalence of this disorder is gaining recognition, the region faces challenges related to societal stigmas and limited healthcare resources in certain areas. However, ongoing efforts to address women's health issues and improve healthcare accessibility contribute to the market's growth. Pharmaceutical companies are increasingly exploring partnerships and market entry strategies to tap into the potential of this region, aiming to provide effective solutions for individuals affected by this disorder.

Leading Key Players in the Endometriosis Industry:

The key players in the market are driving growth through strategic initiatives, research and development, and market expansion. Pharmaceutical companies invest heavily in developing and commercializing innovative therapies for endometriosis. These companies leverage their expertise to create advanced medications that address the specific needs of patients, improving treatment outcomes. Collaborations and partnerships with research institutions further enhance their capabilities in understanding the disease and developing breakthrough solutions. Additionally, key players focus on expanding their market presence through geographical expansion and acquisitions. By entering emerging markets and acquiring smaller companies with promising pipelines, these players secure a competitive edge. Furthermore, they engage in educational initiatives and awareness campaigns, aiming to increase understanding of endometriosis among healthcare professionals and the general public, ultimately driving demand for their products and contributing to the overall growth of the market.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Abbott Laboratories
  • AbbVie Inc.
  • Bayer AG
  • Debiopharm Group
  • Gedeon Richter Plc
  • Kissei Pharmaceutical Co. Ltd.
  • Myovant Sciences GmbH
  • Sanofi S.A.
  • Teva Pharmaceutical Industries Ltd.

Key Questions Answered in This Report:

  • How has the global endometriosis market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global endometriosis market?
  • What is the impact of each driver, restraint, and opportunity on the global endometriosis market?
  • What are the key regional markets?
  • Which countries represent the most attractive endometriosis market?
  • What is the breakup of the market based on the type?
  • Which is the most attractive type in the endometriosis market?
  • What is the breakup of the market based on the diagnosis and treatment?
  • Which is the most attractive diagnosis and treatment in the endometriosis market?
  • What is the breakup of the market based on the end users?
  • Which is the most attractive end users in the endometriosis market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global endometriosis market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Endometriosis Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Superficial Peritoneal Lesion
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Endometrioma
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Deeply Infiltrating Endometriosis
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Diagnosis & Treatment

  • 7.1 Diagnosis
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Ultrasound
      • 7.1.2.2 Pelvic Exam
      • 7.1.2.3 Laparoscopy
      • 7.1.2.4 Magnetic Resonance Imaging (MRI)
      • 7.1.2.5 Hysteroscopy
      • 7.1.2.6 Sonohysterography
    • 7.1.3 Market Forecast
  • 7.2 Treatment
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Hormonal Therapy
      • 7.2.2.2 Pain Management
      • 7.2.2.3 Conservative Surgery
    • 7.2.3 Market Forecast

8 Market Breakup by End Users

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Homecare
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Speciality Centers
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Abbvie Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Bayer AG
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Debiopharm Group
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Gedeon Richter Plc
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Kissei Pharmaceutical Co. Ltd.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Myovant Sciences GmbH
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Sanofi S.A.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Teva Pharmaceutical Industries Ltd.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Endometriosis Market: Sales Value (in Billion USD), 2020-2025
  • Figure 2: Global: Endometriosis Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 3: Global: Endometriosis Market: Breakup by Type (in %), 2025
  • Figure 4: Global: Endometriosis Market: Breakup by Diagnosis & Treatment (in %), 2025
  • Figure 5: Global: Endometriosis Market: Breakup by End Users (in %), 2025
  • Figure 6: Global: Endometriosis Market: Breakup by Region (in %), 2025
  • Figure 7: Global: Endometriosis (Superficial Peritoneal Lesion) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 8: Global: Endometriosis (Superficial Peritoneal Lesion) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 9: Global: Endometriosis (Endometrioma) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Endometriosis (Endometrioma) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Endometriosis (Deeply Infiltrating Endometriosis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Endometriosis (Deeply Infiltrating Endometriosis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Endometriosis (Other Types) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Endometriosis (Other Types) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Endometriosis (Diagnosis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Endometriosis (Diagnosis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Endometriosis (Treatment) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Endometriosis (Treatment) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Endometriosis (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Endometriosis (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Endometriosis (Homecare) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Endometriosis (Homecare) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Endometriosis (Speciality Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Endometriosis (Speciality Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Endometriosis (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Endometriosis (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: North America: Endometriosis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: North America: Endometriosis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: United States: Endometriosis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: United States: Endometriosis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Canada: Endometriosis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Canada: Endometriosis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Asia-Pacific: Endometriosis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Asia-Pacific: Endometriosis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: China: Endometriosis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: China: Endometriosis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Japan: Endometriosis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Japan: Endometriosis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: India: Endometriosis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: India: Endometriosis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: South Korea: Endometriosis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: South Korea: Endometriosis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: Australia: Endometriosis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: Australia: Endometriosis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Indonesia: Endometriosis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: Indonesia: Endometriosis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: Others: Endometriosis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: Others: Endometriosis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: Europe: Endometriosis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: Europe: Endometriosis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Germany: Endometriosis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Germany: Endometriosis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: France: Endometriosis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: France: Endometriosis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: United Kingdom: Endometriosis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: United Kingdom: Endometriosis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: Italy: Endometriosis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: Italy: Endometriosis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: Spain: Endometriosis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: Spain: Endometriosis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Russia: Endometriosis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Russia: Endometriosis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Others: Endometriosis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Others: Endometriosis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Latin America: Endometriosis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Latin America: Endometriosis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Brazil: Endometriosis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Brazil: Endometriosis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Mexico: Endometriosis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Mexico: Endometriosis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Others: Endometriosis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: Others: Endometriosis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Middle East and Africa: Endometriosis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 74: Middle East and Africa: Endometriosis Market: Breakup by Country (in %), 2025
  • Figure 75: Middle East and Africa: Endometriosis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Global: Endometriosis Industry: Drivers, Restraints, and Opportunities
  • Figure 77: Global: Endometriosis Industry: Value Chain Analysis
  • Figure 78: Global: Endometriosis Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Endometriosis Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Endometriosis Market Forecast: Breakup by Type (in Million USD), 2026-2034
  • Table 3: Global: Endometriosis Market Forecast: Breakup by Diagnosis & Treatment (in Million USD), 2026-2034
  • Table 4: Global: Endometriosis Market Forecast: Breakup by End Users (in Million USD), 2026-2034
  • Table 5: Global: Endometriosis Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Endometriosis Market: Competitive Structure
  • Table 7: Global: Endometriosis Market: Key Players